SCHEMBL9634783

SCHEMBL9634783

CON=C(C(=O)Cl)c1ccco1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
PTPN1 P18031 1/20 0.46
SMN1; SMN2 Q16637 6/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
PKM P14618 3/20 0.43
POLB P06746 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KMT2A Q03164 4/20 0.42
GFER P55789 1/20 0.41
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41
APEX1 P27695 1/20 0.41
RECQL P46063 1/20 0.41
MAOB P27338 2/20 0.40
MAPT P10636 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11241406 1.00 CES2 (0.55) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL28412733 1.00 CES2 (0.55) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL11457463 0.85 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL4609969 0.85 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL2812477 0.85 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL13983961 0.85 CES2 (0.52) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL3729527 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL3729528 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL17426488 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2NPC1
SCHEMBL5217865 0.83 CES2 (0.50) CES2CES1PTPN1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109553629-B Preparation method of cefuroxime sodium intermediate E-type impurity compound 浙江永宁药业股份有限公司 2020-06-23 CN disclosed
CN-109553629-B Preparation method of cefuroxime sodium intermediate E-type impurity compound 浙江永宁药业股份有限公司 2020-06-23 CN disclosed
CN-101812076-B Cefuroxime sodium and preparation method thereof LIVZON PHARMACEUTICAL GROUP 2012-05-30 CN disclosed
CN-101671349-B New method for preparing cefuroxime sodium compound HAINAN MEIDA PHARMACEUTICAL CO 2010-12-15 CN disclosed
CN-101812076-A Cefuroxime sodium and preparation method thereof LIVZON PHARMACEUTICAL GROUP 2010-08-25 CN disclosed
CN-101671349-A New method for preparing cefuroxime sodium compound HAINAN MEIDA PHARMACEUTICAL CO 2010-03-17 CN disclosed
US-5084568-A Process for preparing acid halides ELI LILLY AND COMPANY (US) 1992-01-28 US disclosed
US-5013854-A Process for preparing acid halides ELI LILLY AND COMPANY (US) 1991-05-07 US disclosed
EP-0381451-A1 A process for preparing acid halides ELI LILLY AND COMPANY (US) 1990-08-08 EP disclosed
US-4341777-A CRYSTALLIZATION GLAXO GROUP LIMITED (GB) 1982-07-27 US disclosed
US-4278670-A TREATING BACTERIAL INFECTIONS SMITHKLINE CORPORATION (US) 1981-07-14 US disclosed
US-4187375-A CYCLIZATION OF AN AZETIDINONE-1-HYDROXYACETATE; ANTIBIOTIC INTERMEDIATES SMITHKLINE CORPORATION (US) 1980-02-05 US disclosed
US-4162250-A INTERMEDIATES FOR BACTERICIDES SMITHKLINE CORPORATION (US) 1979-07-24 US disclosed
US-4139618-A Cephalosporin type antibacterials SYNTEX (U.S.A.) INC. (US) 1979-02-13 US disclosed
US-4138555-A BACTERICIDES GLAXO LABORATORIES, LIMITED (GB) 1979-02-06 US disclosed
US-4122262-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1978-10-24 US disclosed
US-4112087-A Cephalosporin type antibacterials having a substituted propenyl group in the 3-position SYNTEX (U.S.A.) INC. (US) 1978-09-05 US disclosed
US-4094978-A 3-PROPENYL DERIVATIVES OF CEPHALOSPORIN, COMPOSITIONS AND THEIR USE SYNTEX (U.S.A.) INC. (US) 1978-06-13 US disclosed
US-4089956-A 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof SMITHKLINE CORPORATION (US) 1978-05-16 US disclosed
US-4066762-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1978-01-03 US disclosed